STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

This represents the company’s highest quarterly ICL sales in the U.S. since the company obtained U.S. FDA approval for the EVO ICL in March 2022. “STAAR is off to a solid start in 2024 as ...

Shares of Staar Surgical Co. dropped 25% on Feb. 11 after it surprised Wall Street when it reported fourth quarter sales falling 36% to $49 million.Two weeks later, the Lake Forest-based maker of ...

"It sounds crazy but it has made such a big difference." EVO ICL stands for EVO Implantable Collamer Lens. EVO is a breakthrough, CE and FDA-approved implantable lens for people who have trouble ...

LAKE FOREST, Calif., February 26, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL ...

You can schedule your LASIK or EVO ICL consult online at keywhitnan.com/schedule or text/call (214) 935-5618.

The company markets and sells these lenses under the "EVO" family for refractive surgery to treat myopia (nearsightedness). ICL sales were $46.9 million for the fourth quarter of 2024 compared to ...

In this exclusive interview with Sky Sports, Chelsea and England full-back Lucy Bronze discusses her decision to undergo eye ...